These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


196 related items for PubMed ID: 16924243

  • 1. Human tumor suppressor p14ARF negatively regulates rRNA transcription and inhibits UBF1 transcription factor phosphorylation.
    Ayrault O, Andrique L, Fauvin D, Eymin B, Gazzeri S, Séité P.
    Oncogene; 2006 Dec 07; 25(58):7577-86. PubMed ID: 16924243
    [Abstract] [Full Text] [Related]

  • 2. Involvement of the transcriptional factor E2F1 in the regulation of the rRNA promoter.
    Ayrault O, Andrique L, Séité P.
    Exp Cell Res; 2006 Apr 15; 312(7):1185-93. PubMed ID: 16510138
    [Abstract] [Full Text] [Related]

  • 3. [The negative regulation of ribosome biogenesis: a new Arf-dependent pathway controlling cell proliferation?].
    Ayrault O, Andrique L, Larsen CJ, Séité P.
    Med Sci (Paris); 2006 May 15; 22(5):519-24. PubMed ID: 16687121
    [Abstract] [Full Text] [Related]

  • 4. Human Arf tumor suppressor specifically interacts with chromatin containing the promoter of rRNA genes.
    Ayrault O, Andrique L, Larsen CJ, Seite P.
    Oncogene; 2004 Oct 21; 23(49):8097-104. PubMed ID: 15361825
    [Abstract] [Full Text] [Related]

  • 5. Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts.
    Lindström MS, Wiman KG.
    Oncogene; 2003 Aug 07; 22(32):4993-5005. PubMed ID: 12902982
    [Abstract] [Full Text] [Related]

  • 6. p14ARF interacts with E2F factors to form p14ARF-E2F/partner-DNA complexes repressing E2F-dependent transcription.
    Zhang HJ, Li WJ, Gu YY, Li SY, An GS, Ni JH, Jia HT.
    J Cell Biochem; 2010 Mar 01; 109(4):693-701. PubMed ID: 20082327
    [Abstract] [Full Text] [Related]

  • 7. Human papillomavirus 16 oncoprotein E7 stimulates UBF1-mediated rDNA gene transcription, inhibiting a p53-independent activity of p14ARF.
    Dichamp I, Séité P, Agius G, Barbarin A, Beby-Defaux A.
    PLoS One; 2014 Mar 01; 9(5):e96136. PubMed ID: 24798431
    [Abstract] [Full Text] [Related]

  • 8. 8-Chloro-adenosine-induced E2F1 promotes p14ARF gene activation in H1299 cells through displacing Sp1 from multiple overlapping E2F1/Sp1 sites.
    Zhang HJ, Li WJ, Yang SY, Li SY, Ni JH, Jia HT.
    J Cell Biochem; 2009 Feb 15; 106(3):464-72. PubMed ID: 19115249
    [Abstract] [Full Text] [Related]

  • 9. Nucleolar localization of aprataxin is dependent on interaction with nucleolin and on active ribosomal DNA transcription.
    Becherel OJ, Gueven N, Birrell GW, Schreiber V, Suraweera A, Jakob B, Taucher-Scholz G, Lavin MF.
    Hum Mol Genet; 2006 Jul 15; 15(14):2239-49. PubMed ID: 16777843
    [Abstract] [Full Text] [Related]

  • 10. In vitro and in vivo analysis of the interaction between 5.8S rRNA and ARF protein reveal a new difference between murine p19ARF and human p14ARF.
    Andrique L, Ayrault O, Larsen CJ, Séité P.
    Oncogene; 2005 Apr 07; 24(15):2580-4. PubMed ID: 15735732
    [Abstract] [Full Text] [Related]

  • 11. Ubiquitination of, and sumoylation by, the Arf tumor suppressor.
    den Besten W, Kuo ML, Tago K, Williams RT, Sherr CJ.
    Isr Med Assoc J; 2006 Apr 07; 8(4):249-51. PubMed ID: 16671360
    [Abstract] [Full Text] [Related]

  • 12. ARF antagonizes the ability of Miz-1 to inhibit p53-mediated transactivation.
    Miao L, Song Z, Jin L, Zhu YM, Wen LP, Wu M.
    Oncogene; 2010 Feb 04; 29(5):711-22. PubMed ID: 19901969
    [Abstract] [Full Text] [Related]

  • 13. Dual regulation of upstream binding factor 1 levels by IRS-1 and ERKs in IGF-1-receptor signaling.
    Sun H, Tu X, Liu M, Baserga R.
    J Cell Physiol; 2007 Sep 04; 212(3):780-6. PubMed ID: 17443674
    [Abstract] [Full Text] [Related]

  • 14. The ARF tumour suppressor.
    Gallagher SJ, Kefford RF, Rizos H.
    Int J Biochem Cell Biol; 2006 Sep 04; 38(10):1637-41. PubMed ID: 16600663
    [Abstract] [Full Text] [Related]

  • 15. AP-1 dimers regulate transcription of the p14/p19ARF tumor suppressor gene.
    Ameyar-Zazoua M, Wisniewska MB, Bakiri L, Wagner EF, Yaniv M, Weitzman JB.
    Oncogene; 2005 Mar 31; 24(14):2298-306. PubMed ID: 15688012
    [Abstract] [Full Text] [Related]

  • 16. Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant.
    Colombo E, Martinelli P, Zamponi R, Shing DC, Bonetti P, Luzi L, Volorio S, Bernard L, Pruneri G, Alcalay M, Pelicci PG.
    Cancer Res; 2006 Mar 15; 66(6):3044-50. PubMed ID: 16540653
    [Abstract] [Full Text] [Related]

  • 17. E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway.
    Russell JL, Weaks RL, Berton TR, Johnson DG.
    Oncogene; 2006 Feb 09; 25(6):867-76. PubMed ID: 16205640
    [Abstract] [Full Text] [Related]

  • 18. Induction of p14ARF by E2F1 contributes to 8-chloro-adenosine-induced apoptosis in human lung cancer H1299 cells.
    Li WJ, Gu YY, Zhang HJ, Zhou J, Jia HT.
    Chemotherapy; 2009 Feb 09; 55(5):335-43. PubMed ID: 19641316
    [Abstract] [Full Text] [Related]

  • 19. p14ARF interacts with N-Myc and inhibits its transcriptional activity.
    Amente S, Gargano B, Diolaiti D, Della Valle G, Lania L, Majello B.
    FEBS Lett; 2007 Mar 06; 581(5):821-5. PubMed ID: 17289033
    [Abstract] [Full Text] [Related]

  • 20. p14ARF regulates E2F-1 ubiquitination and degradation via a p53-dependent mechanism.
    Rizos H, Scurr LL, Irvine M, Alling NJ, Kefford RF.
    Cell Cycle; 2007 Jul 15; 6(14):1741-7. PubMed ID: 17630509
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.